產(chǎn)品詳情
中文名稱:替卡格雷 | 英文名稱:TICAGRELOR;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;Azd 6140;Unii-glh0314rvc;(1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;AR-C 126532XX;Ticagrelor(AR-C 126532XX |
CAS:274693-27-5 | 有效期: 一個月 |
2013-01-30
替卡格雷
TICAGRELOR;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;Azd 6140;Unii-glh0314rvc;(1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;AR-C 126532XX;Ticagrelor(AR-C 126532XX
RMB
一個月
Twisun can provide Ticagrelor and its intermediates, & all the related tech docs, even the DMF.
(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
4-Bromo-1,2-pyrazolidinedicarboxaldehyde
(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol oxalate
4,6-Dichloro-5-nitro-2-propylthiopyrimidine
Ethanol,2-[[(3aR,4S,6R,6aS)-6-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate
關(guān)鍵字: CAS 274693-27-5 ticagrelor intermediates
公司簡介
Shanghai Twisun Bio-pharm Co., Ltd. is a leading professional high technology manufacturer of Intermediates and API’s which was established in Shanghai in 2007. It’s located in the national high-tech business park "Shanghai Torch Innovation Park of Fine chemical Industry".
成立日期 |
|
注冊資本 |
|
員工人數(shù) |
|
年營業(yè)額 |
|
主營行業(yè) |
|
經(jīng)營模式 |
|